“Ordered, Intimidated And Coerced”? CDRH Targeted In Misconduct Probe
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center has until Dec. 1 to respond to a Congressional inquiry into allegations of wrongdoing in its pre-market review process